| Tissue-specific and pathogen-specific toxic agents and ribozymes J Norris, G Clawson, C Westwater, D Schofield, M Schmidt, B Hoel, ... US Patent 6,271,359, 2001 | 360 | 2001 |
| Use of genetically engineered phage to deliver antimicrobial agents to bacteria: an alternative therapy for treatment of bacterial infections C Westwater, LM Kasman, DA Schofield, PA Werner, JW Dolan, ... Antimicrobial agents and chemotherapy 47 (4), 1301-1307, 2003 | 316 | 2003 |
| Overcoming the phage replication threshold: a mathematical model with implications for phage therapy LM Kasman, A Kasman, C Westwater, J Dolan, MG Schmidt, JS Norris Journal of virology 76 (11), 5557-5564, 2002 | 251 | 2002 |
| Clinical relevance of ceramide metabolism in the pathogenesis of human head and neck squamous cell carcinoma (HNSCC): Attenuation of C18-ceramide in HNSCC tumors correlates … S Karahatay, K Thomas, S Koybasi, CE Senkal, S ElOjeimy, X Liu, ... Cancer letters 256 (1), 101-111, 2007 | 223 | 2007 |
| Nuclear factor-κB/IκB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells Y Huang, KR Johnson, JS Norris, W Fan Cancer research 60 (16), 4426-4432, 2000 | 210 | 2000 |
| Vorinostat and sorafenib increase ER stress, autophagy and apoptosis via ceramide-dependent CD95 and PERK activation MA Park, G Zhang, AP Martin, H Hamed, C Mitchell, PB Hylemon, M Graf, ... Cancer biology & therapy 7 (10), 1648-1662, 2008 | 204 | 2008 |
| Genome characterization of the oleaginous fungus Mortierella alpina L Wang, W Chen, Y Feng, Y Ren, Z Gu, H Chen, H Wang, MJ Thomas, ... PloS one 6 (12), e28319, 2011 | 181 | 2011 |
| Molecular cloning, tissue distribution, and expression of a 14-kDa bile acid-binding protein from rat ileal cytosol. YZ Gong, ET Everett, DA Schwartz, JS Norris, FA Wilson Proceedings of the National Academy of Sciences 91 (11), 4741-4745, 1994 | 171 | 1994 |
| Mechanism of androgen-receptor augmentation. Analysis of receptor synthesis and degradation by the density-shift technique. AJ Syms, JS Norris, WB Panko, RG Smith Journal of Biological Chemistry 260 (1), 455-461, 1985 | 156 | 1985 |
| Atrial natriuretic prohormone peptides 1–30, 31–67, and 79–98 vasodilate the aorta DL Vesely, JS Norris, JM Walters, RR Jespersen, DA Baeyens Biochemical and biophysical research communications 148 (3), 1540-1548, 1987 | 153 | 1987 |
| Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL C Voelkel-Johnson, DL King, JS Norris Cancer Gene Therapy 9 (2), 164-172, 2002 | 150 | 2002 |
| Acid ceramidase upregulation in prostate cancer cells confers resistance to radiation: AC inhibition, a potential radiosensitizer AEM Mahdy, JC Cheng, J Li, S Elojeimy, WD Meacham, LS Turner, A Bai, ... Molecular Therapy 17 (3), 430-438, 2009 | 146 | 2009 |
| The functional effects of acid ceramidase over-expression in prostate cancer progression and resistance to chemotherapy AF Saad, WD Meacham, A Bai, V Anelli, V Anelli, AEM Mahdy, LS Turner, ... Cancer biology & therapy 6 (9), 1451-1456, 2007 | 144 | 2007 |
| CA 125 antigen in human amniotic fluid and fetal membranes TJ O'Brien, JW Hardin, GA Bannon, JS Norris, G Quirk Jr American journal of obstetrics and gynecology 155 (1), 50-55, 1986 | 141 | 1986 |
| New insights on the use of desipramine as an inhibitor for acid ceramidase S Elojeimy, DH Holman, X Liu, A El-Zawahry, M Villani, JC Cheng, ... FEBS letters 580 (19), 4751-4756, 2006 | 135 | 2006 |
| Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse JC Cheng, A Bai, TH Beckham, ST Marrison, CL Yount, K Young, P Lu, ... The Journal of clinical investigation 123 (10), 4344-4358, 2013 | 126 | 2013 |
| Intracellular Fas ligand expression causes Fas-mediated apoptosis in human prostate cancer cells resistant to monoclonal antibody-induced apoptosis ML Hyer, C Voelkel-Johnson, S Rubinchik, J Dong, JS Norris Molecular Therapy 2 (4), 348-358, 2000 | 109 | 2000 |
| Role of acid ceramidase in resistance to FasL: therapeutic approaches based on acid ceramidase inhibitors and FasL gene therapy S Elojeimy, X Liu, JC Mckillop, AM El-Zawahry, DH Holman, JY Cheng, ... Molecular therapy 15 (7), 1259-1263, 2007 | 106 | 2007 |
| Androgen receptors in a Syrian hamster ductus deferens tumour cell line JS Norris, J Gorski, PO Kohler Nature 248 (5447), 422-424, 1974 | 102 | 1974 |
| Lysosomotropic acid ceramidase inhibitor induces apoptosis in prostate cancer cells DH Holman, LS Turner, A El-Zawahry, S Elojeimy, X Liu, J Bielawski, ... Cancer chemotherapy and pharmacology 61, 231-242, 2008 | 97 | 2008 |
